TVTX
Travere Therapeutics Inc
52.00$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.49 | 0.59 | 0.54 | 0.70 | 0.81 | 0.90 | 0.93 | 1.29 | 1.61 | 1.44 | 1.38 | 1.81 | 6.33 | |
| 0.02 | 0.21 | 0.02 | 0.16 | 0.02 | 0.03 | 0.05 | 0.02 | 0.02 | 0.03 | 0.29 | 0.02 | 0.35 | |
| 0.47 | 0.37 | 0.52 | 0.54 | 0.79 | 0.87 | 0.87 | 1.27 | 1.59 | 1.41 | 1.09 | 1.79 | 5.97 | |
| 0.79 | 0.77 | 1.49 | 0.70 | 0.66 | 0.75 | 0.53 | 0.55 | 0.51 | 0.64 | 0.62 | 0.64 | 2.43 | |
| 0.89 | 0.83 | 0.83 | 0.84 | 0.84 | 0.84 | 0.82 | 0.86 | 0.84 | 1.13 | 0.87 | 1.03 | 3.90 | |
| 1.68 | 1.46 | 2.32 | 1.40 | 1.51 | 1.60 | 1.36 | 1.41 | 1.35 | 1.77 | 1.50 | 1.75 | 6.40 | |
| -1.21 | -1.08 | -1.81 | -0.87 | -0.72 | -0.73 | -0.48 | -0.14 | 0.24 | -0.36 | -0.40 | 0.04 | -0.43 | |
| 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.10 | |
| -1.17 | -1.16 | -1.76 | -0.90 | -0.71 | -0.73 | -0.47 | -0.14 | 0.25 | -0.23 | -0.40 | -0.37 | -0.72 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | |
| 1.98 | -1.18 | -1.76 | -0.91 | -0.70 | -0.73 | -0.47 | -0.14 | 0.25 | 0.03 | -0.40 | -0.37 | -0.46 | |
| -0.98 | -0.97 | -1.60 | -0.73 | -0.52 | -0.55 | -0.29 | 0.05 | 0.43 | -0.01 | -0.10 | -0.31 | 0.06 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.